Related Experiment Videos
Continuous ambulatory peritoneal dialysis complicated by Aureobasidium pullulans peritonitis
E C Clark1, S M Silver, G E Hollick
1Department of Medicine, Rochester General Hospital/Nephrology Unit, University of Rochester School of Medicine and Dentistry, NY 14621, USA.
American Journal of Nephrology
|January 1, 1995
Summary
Aureobasidium pullulans rarely causes infections but can lead to peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients. Successful treatment involved catheter removal and amphotericin B, enabling a return to CAPD.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Nephrology
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is a common treatment for end-stage renal disease.
- Peritonitis is a serious complication of CAPD, often caused by bacteria.
- Fungal peritonitis in CAPD patients is rare, with limited reported causative agents.
Observation:
- A case of peritonitis in a CAPD patient was caused by Aureobasidium pullulans, a fungus not previously reported in this context.
- Aureobasidium pullulans is a dematiaceous fungus known for its rarity in human infections.
- The patient presented with symptoms indicative of peritonitis.
Findings:
- In vitro susceptibility testing demonstrated that the isolated Aureobasidium pullulans strain was sensitive to amphotericin B.
- The patient was successfully treated with a combination of peritoneal catheter removal and a prolonged course of intravenous amphotericin B.
- Successful management allowed the patient to resume CAPD therapy.
Implications:
- This case expands the known spectrum of fungal pathogens causing peritonitis in CAPD patients.
- It highlights the importance of considering rare fungal etiologies in refractory or unusual cases of CAPD peritonitis.
- Amphotericin B is confirmed as an effective treatment option for Aureobasidium pullulans peritonitis in CAPD.